FAT1 and lung adenocarcinoma: Immunoblotting was used to detect the differential expression of FAT1 in lung epithelial cells and various lung cancer cell lines, while immunohistochemistry was employed to assess FAT1 expression in lung cancer and adjacent tissues.<h4>Results</h4>FAT1 gene mutations were identified in 14% of lung adenocarcinoma patients.